Results 1 to 10 of about 378,588 (317)
Stopping Tuberculosis at the Gate: The Role of <i>M. tuberculosis</i> Adhesins in Infection and Intervention. [PDF]
Vaccines (Basel)The global burden of tuberculosis (TB), exacerbated by the rise of drug-resistant Mycobacterium tuberculosis (M. tuberculosis), underscores the need for alternative intervention strategies. One promising approach is to block the infection at its earliest stage—bacterial adhesion to host cells—thereby preventing colonization and transmission without ...
Yang H +7 more
europepmc +4 more sources
Development of pulmonary tuberculosis in the patient with systemic sarcoidosis and brain involvement
Туберкулез и болезни лёгких, 2021 The article presents a clinical case of pulmonary tuberculosis with destruction and bacterial excretion in the patient with systemic sarcoidosis and cerebral lesions.
E. V. Korzh +3 more
doaj +1 more source
Туберкулез и болезни лёгких, 2021 The article describes a clinical case of treatment of multiple drug resistant tuberculosis in the patient with type 1 diabetes mellitus who had received a kidney transplant (from his mother) 3 years before tuberculosis was diagnosed due to diabetic ...
E. V. Korzh +2 more
doaj +1 more source
Difficulty of tuberculosis diagnostics in general health care institutions
Клинический разбор в общей медицине, 2023 Aim. The aim of the study is to analyze the reasons for the erroneous diagnostics of TB in the general health care institutions and identify ways to improve diagnostics. Materials and methods.
Elena V. Korzh +3 more
doaj +1 more source
Concomitant immunity to M. tuberculosis infection
Scientific Reports, 2022 Abstract Some persistent infections provide a level of immunity that protects against reinfection with the same pathogen, a process referred to as concomitant immunity. To explore the phenomenon of concomitant immunity during Mycobacterium tuberculosis infection, we utilized
Louis R. Joslyn +3 more
openaire +3 more sources
Туберкулез и болезни лёгких, 2020 The objective: to analyze treatment efficacy and causes of tuberculosis relapses in HIV-infected patients with severe immunosuppression who have started antiretroviral therapy (ART). Subjects and methods.
E. V. Korzh +4 more
doaj +1 more source
Туберкулез и болезни лёгких, 2023 The objective: to assess the stability of circulation of S genotype and S-like strains of M. tuberculosis (MTB) in the Republic of Sakha (Yakutia) over a 12-year period and perform their phylogenetic identification relative to the L4.4 Euro-American ...
V. V. Sinkov +5 more
doaj +1 more source
M. tuberculosis: immunology and vaccination [PDF]
European Respiratory Journal, 2001 Tuberculosis is increasing. Current treatment regimens require at least 6 months, because latent or stationary phase organisms are difficult to kill. Such regimens do not achieve full compliance, and “directly observed therapy short course” (DOTS) is having less impact than expected.
G A, Rook, G, Seah, A, Ustianowski
openaire +2 more sources
M tuberculosis drug resistance in AIDS [PDF]
The Lancet, 1997 SIR—Bradford and associates (Oct 5, p 928) describe an increase of acquired drug resistance of Mycobacterium tuberculosis isolates chronologically associated with the trend of AIDSassociated tuberculosis in the USA between 1985 and 1994. The 14 resistant cases recorded were found to correlate with several behavioural and other individual factors within
DI PERRI G +4 more
openaire +2 more sources
Immunogenic Activity of Lipids of M. tuberculosis [PDF]
Nature, 1965 LIPIDS of mycobacteria are known to be immunogenically active components of tubercle bacilli1. First of all, it was surprising that mycobacteria contain lipids up to 35 per cent of their dry weight2. This fact did not escape the notice of immunologists.
B, Stöss, R, Herrmann
openaire +2 more sources